Switzerland health care reform act

Health reforms in Switzerland require a particularly large consensus in order to be adopted and implemented. Reaching such a consensus is complicated – sometimes impossible – and almost always takes a very long time (Bolgiani, Crivelli & Domenighetti, 2006). However, the lengthy and difficult process of consensus seeking is also an important strength of the political system because it ensures that passed reforms are supported (or at least not opposed) by all relevant stakeholders.

Extensive consultations with cantons and other stakeholders, including with corporatist bodies and civil society organizations, during the early phases of reforms often lead to the incorporation of legitimate concerns into reform proposals. The possibility for the population (or pressure groups that are successful at mobilizing popular support) to veto reforms or demand change through public referendum imposes strong popular control. Therefore, the government has to make sure that it has good arguments in favour of proposed changes, meaning that reform proposals have to be based on solid policy analyses and implemented reforms will usually undergo rigorous evaluations.

Reforms or significant developments can be initiated in Switzerland by several actors and via different policy paths. Reforms of federal laws are usually proposed by the Federal Council or Parliament. However, other reforms or significant developments are initiated by cantons either independently or jointly via the GDK/CDS , while still others are started by corporatist bodies or via popular initiatives.

Table6.1 summarizes major reforms and reform attempts as well as other significant developments that occurred in the health system between 2000 and 2014. As KVG/LAMal is the most important federal law outlining the basic characteristics of the health system (see section 2.1), most reforms are, in fact, revisions of KVG/LAMal . The most important areas of reform were:

Table

Before discussing these reforms in more detail, section 6.1.1 describes the context and origin of several of these reforms to illustrate the long, difficult and not always successful political processes of making health reforms in Switzerland.

One important trend across all reforms since 2000 (and even before that) has been a tendency towards more harmonization of national health policy-making (see section 2.4). Many reforms have strengthened the role of the federal government, which has obtained more influence on hospital inpatient care provision, insurance supervision and public health. In addition, cantons are increasingly coordinating their activities, leading to a stronger role for the GDK/CDS and the need for more formal collaboration with the federal government through the National Dialogue on Health Policy. Nevertheless, reforms leading to a stronger role for the federal government are often highly contested as cantons are reluctant to allow more federal intervention in one of their core competences.

10 October 2022 | Country Update

Revision of the Federal Law on Tobacco Products and Electronic Cigarettes

After the approval of the popular initiative “Yes to protecting children and young adults from tobacco advertising” adopted on 13 February 2022, the Federal Council decided on 31 August 2022 to conduct a consultation procedure for the revision of the Federal Law on Tobacco Products and Electronic Cigarettes to further protect young people.

Switzerland has one of the weakest federal tobacco control measures in place in Europe: advertising of tobacco products is permitted except for certain restrictions, although many cantons have more far-reaching bans in place. This initiative aims to ban tobacco advertising that reaches children and adolescents and to ban sponsoring events such as festivals by the tobacco and electronic cigarette industry that are accessible to minors.

The currently planned revision of tobacco advertising concerns the Tobacco Products Act, which was already adopted by Parliament on 1 October 2021, even before the vote on the popular initiative. It also regulates electronic cigarettes and herbal smoking products, including in particular hemp-based smoking products with a low THC content and containing CBD. The Act is expected to enter into force at the beginning of 2024.

Authors
Related Content